Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-03-04 @ 10:59 AM
Study NCT ID:
NCT03903406
Status:
UNKNOWN
Last Update Posted:
2019-04-04
First Post:
2019-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study
Sponsor:
Multinational Center for Quality of Life Research, Russia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-11
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-01
First Submit QC Date:
None
Study First Post Date:
2019-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-02
Last Update Post Date:
2019-04-04
Last Update Post Date Type:
ACTUAL